News Opinion CV Team Dispatch September 2025 Dispatch for the CV Team L.A. McKeown September 30, 2025
News Daily News Access to GLP-1 Drugs Unequal for US Patients With Obesity Caitlin E. Cox May 01, 2025
News Daily News HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF L.A. McKeown October 01, 2024
News Daily News As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness L.A. McKeown June 05, 2024
News Daily News Peer Coaching May Help With BP Control in Rural Black Populations Todd Neale March 22, 2024
News Daily News Optimal Care Reported in Less Than Half of Adults With ASCVD Yael L. Maxwell December 05, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Conference News TCT 2022 Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus Yael L. Maxwell September 16, 2022
News Daily News CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans Yael L. Maxwell July 22, 2022
News Daily News Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained Yael L. Maxwell July 15, 2022
News Daily News Comorbidities May Drive PAD Procedural Outcomes in Black Patients L.A. McKeown June 23, 2022
News Conference News HRS 2022 Racial/Ethnic Disparities in Anticoagulation Persist in Hospitalized AF Patients Todd Neale April 29, 2022
News Conference News AHA 2021 Racial/Ethnic Disparities in AF Care Persist Despite Dual VA, Medicare Coverage Todd Neale November 19, 2021
News Daily News ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores Shelley Wood July 12, 2021
News Daily News Despite COVID-19, Heart Disease Remains Top US Killer: AHA Michael O'Riordan January 28, 2021